Though the neighborhood is normally relatively peaceful, Mainville said the malfunctioning foghorn at the end of the jetty is testing his nerves. “Over and over and over,” he said.

We've been pushing the state of the art on how you do AI and machine learning on high-velocity data,' FogHorn CEO David King tells CRN about the startup's edge intelligence capabilities.

Foghorn Therapeutics Inc. announced continued enrollment in its Phase 1 trial for FHD-909, a first-in-class oral selective SMARCA2 inhibitor targeting SMARCA4 mutated cancers, particularly non ...